high drug cost medicar rep fortney h stark oakland would like see american receiv fair deal medicar dollar agre bad extend deal epogen manufactur amgen aug 2 column miracl drug tax drain stark charg amgen reap untold profit medicar drug epogen revolutionari treatment anemia suffer kidney dialysi patient cannot understand stark vilifi epogen along lead nephrologist call miracl drug first stark appear confus revenu profit true industri analyst project annual revenu exceed 100 million product money reach amgen cours manufactur expect enter market soon stark estim cost epogen less cost packag breakthrough product importantli amgen revenu spent larg research develop fact amgen rank first american compani amount spend research develop per employe percent revenu accord recent survey busi week second stark know amgen extort anyth anyon medicar roll play dead repres health care financ administr hcfa compani particip spirit discuss last nearli year end hcfa establish reimburs rate govern found equit u price epogen 30 less europ third stark impli epogen valuabl gold gram epogen provid week worth treatment 8 000 patient elimin 1 000 blood transfus make epogen better pure gold say ye dialysi patient amgen concern stark rise cost health care present inform staff sen david pryor ark hear drug price work close hcfa difficult understand stark alarm fathom feel need belittl compani achiev make epogen realiti gordon binder amgen chief execut offic thousand oak